mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |